NeOnc Technologies to Be Featured on Health Uncensored with Dr. Drew to Discuss Reaching Brain Tumors Without Surgery or Systemic Chemotherapy
Key Highlights
- ➤NeOnc to appear on Fox Business Network’s Health Uncensored segment October 25
- ➤NEO100 investigational program is in clinical development in adults and children
- ➤NEO100 uses intranasal delivery designed to reach brain tumors non-invasively
- ➤NEO212 completed Phase 1 dose escalation and is advancing toward Phase 2
Expert Statements
Amir F. Heshmatpour, Executive Chairman, President and Chief Executive Officer of NeOnc Technologies
“We believe that we will make a significant impact in the standard of care for adults and kids suffering with brain cancer.”
CALABASAS, Calif., Oct. 22, 2026 (GLOBE NEWSWIRE) -- NeOnc Technologies Holdings, Inc. (Nasdaq: NTHI) (“NeOnc” or the “Company”), a clinical-stage biopharmaceutical company developing therapies for central nervous system (CNS) cancers, today announced that it will be featured on Health Uncensored with Dr. Drew, a national health television series hosted by Dr. Drew Pinsky, in a segment on non-invasive approaches to delivering investigational therapies to brain tumors.
Fox Business Network will carry the segment on Sunday, October 25, 2026, at 5:30 p.m. ET / 2:30 p.m. PT. Air dates and times are subject to change.
Get started
Create a free account to read the full story.